How we treat medulloblastoma in adults

por Franceschi, E., Seidel, C., Sahm, F., Pajtler, K.W., Hau, P.
Publicado 2021

Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches

por Ellis, H. P., McInerney, C. E., Schrimpf, D., Sahm, F., Stupnikov, A., Wadsley, M., Wragg, C., White, P., Prise, K. M., McArt, D. G., Kurian, K. M.
Publicado 2019

Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System

por Abu Hejleh, AP, Huck, K, Jähne, K, Tan, CL, Lanz, TV, Epping, L, Sonner, JK, Meuth, SG, Henneberg, A, Opitz, CA, Herold-Mende, C, Sahm, F, Platten, M, Sahm, K
Publicado 2023

Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial

por Wick, A., Sander, A., Koch, M., Bendszus, M., Combs, S., Haut, T., Dormann, A., Walter, S., Pertz, M., Merkle-Lock, J., Selkrig, N., Limprecht, R., Baumann, L., Kieser, M., Sahm, F., Schlegel, U., Winkler, F., Platten, M., Wick, W., Kessler, T.
Publicado 2022